- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production ; volume:15 ; number:1 ; day:17 ; month:9 ; year:2024 ; pages:1-2 ; date:12.2024
Nature Communications ; 15, Heft 1 (17.9.2024), 1-2, 12.2024
- Creator
-
Tribble, James R.
Jöe, Melissa
Varricchio, Carmine
Otmani, Amin
Canovai, Alessio
Habchi, Baninia
Daskalakis, Evangelia
Chaleckis, Romanas
Loreto, Andrea
Gilley, Jonathan
Wheelock, Craig E.
Jóhannesson, Gauti
Wong, Raymond C. B.
Coleman, Michael P.
Brancale, Andrea
Williams, Pete A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-024-52439-7
- URN
-
urn:nbn:de:101:1-2411302105142.120844653318
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:19 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tribble, James R.
- Jöe, Melissa
- Varricchio, Carmine
- Otmani, Amin
- Canovai, Alessio
- Habchi, Baninia
- Daskalakis, Evangelia
- Chaleckis, Romanas
- Loreto, Andrea
- Gilley, Jonathan
- Wheelock, Craig E.
- Jóhannesson, Gauti
- Wong, Raymond C. B.
- Coleman, Michael P.
- Brancale, Andrea
- Williams, Pete A.
- SpringerLink (Online service)
Other Objects (12)
NMNAT2 is a druggable target to drive neuronal NAD production
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
In search of druggable targets for GBM amino acid metabolism
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets
Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
NMNAT2 is a druggable target to drive neuronal NAD production
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
In search of druggable targets for GBM amino acid metabolism
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets
Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
NMNAT2 is a druggable target to drive neuronal NAD production
Cysteine metabolic circuitries: druggable targets in cancer
Network analysis of atherosclerotic genes elucidates druggable targets
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington’s disease
In search of druggable targets for GBM amino acid metabolism
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Kinase profiling of liposarcomas using RNAi and drug screening assays identified druggable targets